Searched for
ZCL CHEMICALS
Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...- Suven-Cohance Lifesciences merger announced to create 1st listed PE-led contract manufacturer in Indian pharmaSuven has been 50% owned by Advent since 2022 acquisition, with the remaining with public and institutional shareholders while Cohance is w...
- ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...
- US-based Advent seeking investors for Suven-Cohance mergerAdvent announced its acquisition of Suven Pharma in December. Including the cost of the open offer, the deal size would go up to Rs 9,589 c...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Suven Pharma falls 2% as Advent picks majority stake in the companyPost the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
- PE firm Advent names its India API, CDMO platform as Cohance LifesciencesThe US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to become one ...
- Zandu scion Nihar Parikh sets up a family office for healthcare bets4Point0 Health Ventures will deploy about $75 million into the sector and will cut $1-2 million cheques.
- Advent buys controlling stake in Avra Labs for $100 millionThe transaction is Advent’s fifth investment in India over the past 12 months
- Bought for Rs 12.5 cr, sold at Rs 2000 cr; How Zandu scion scaled API business 160 times in 12 yearsNihar Parikh has sold 100% of ZCL, an API co to Advent International riding the industry upswing after turning around a once-sub scale oper...
- Solara promoter, TPG plan to sell stake in companyThe company has seen a near five-fold jump in its share price, giving promoters Kumar and his partner KR Ravishankar an additional reason t...
- PE firm Advent to buy controlling stake in ZCL Chemicals for Rs 1,700 croreZCL manufactures specialty active pharmaceutical ingredients (APIs) and advanced intermediates, with a focus on niche therapeutic areas and...
- PE fund Advent International to buy ZCL ChemicalsAdvent will buy about 51% stake in ZCL at an enterprise value of Rs1700 crore, said sources in the know. With this transaction, existing in...
- Morgan Stanley PE Asia buys 20% in ZCL for Rs 170 croreThe capital, raised from the private equity arm of global financial services company Morgan Stanley, will be used to fund the company’s gro...
- ZCL raises Rupees 170 cr from Morgan Stanley PEZCL said it is a speciality pharma company focusing on niche therapeutic areas of central nervous system (CNS), anti-retroviral (ARV) and c...
- Morgan Stanley to purchase 20% stake in ZCL Chemicals for Rs 180 croreNihar Parikh, executive director of ZCL, declined to comment on the fund raising and stake sale plans of the company.
- Kedaara Capital set to buy 20% stake in ZCL Chemicals for about Rs 180 croreKedaara Capital is close to picking up around 20 per cent stake in ZCL Chemicals Ltd, formerly known as Zandu Chemicals.
Load More
